题名 | Results from a Phase 1b Study of UCB0599, an Orally Available, Brain-penetrant Inhibitor of Alphasynuclein (ASYN) Misfolding in People Living with Parkinson’s Disease (PD) (2025) | 链接 | https://n.neurology.org/content/96/15_Supplement/2025 |
https://n.neurology.org/content/96/15_Supplement/2025 |